Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switching From Tobramycin Inhalation Treatment to Tobramycin Inhaler Treatment: The Effect on CF Patients' Adherence and Quality of Life

NCT01749644 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT01749644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01749644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switching From Tobramycin Inhalation Treatment to Tobramycin Inhaler Treatment: The Effect on CF Patients' Adherence and Quality of Life
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2013
Completion date
January 31, 2015
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alteration in quality of life of cf patients, following change of treatment from antibiotic inhalation to antibiotic inhaler